November 11, 2013

AngioDynamics' AngioVac Receives CE Mark Approval

October 29, 2013—AngioDynamics (Latham, NY) announced European CE Mark approval for the company's AngioVac venous drainage cannula and cardiopulmonary bypass circuit for use during extracorporeal bypass for up to 6 hours. The CE Mark approval for the AngioVac cannula also includes an indication for removal of fresh, soft thrombi or emboli.

According to AngioDynamics, the AngioVac cannula and circuit, when combined with other manufacturers' filters, pumps, and return cannula, comprise an extracorporeal bypass circuit that facilitates drainage, filtration, and reinfusion of blood for up to 6 hours. The AngioVac cannula is composed of the company's balloon-actuated, expandable, funnel-shaped distal tip that enhances flow, prevents clogging of the cannula, and facilitates en bloc removal of undesirable intravascular material.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

November 11, 2013

AngioDynamics' AngioVac Receives CE Mark Approval

Current Issue

Keep In Touch